| Targeting WNT signaling for multifaceted glioblastoma therapy M McCord, YS Mukouyama, MR Gilbert, S Jackson Frontiers in cellular neuroscience 11, 318, 2017 | 112 | 2017 |
| Multiple cerebral hemorrhages in a patient receiving lecanemab and treated with t-PA for stroke NJ Reish, P Jamshidi, B Stamm, ME Flanagan, E Sugg, M Tang, ... New England Journal of Medicine 388 (5), 478-479, 2023 | 103 | 2023 |
| Extensive brainstem infiltration, not mass effect, is a common feature of end-stage cerebral glioblastomas MR Drumm, KS Dixit, S Grimm, P Kumthekar, RV Lukas, JJ Raizer, ... Neuro-oncology 22 (4), 470-479, 2020 | 79 | 2020 |
| ERK1/2 phosphorylation predicts survival following anti-PD-1 immunotherapy in recurrent glioblastoma VA Arrieta, AX Chen, JR Kane, SJ Kang, C Kassab, C Dmello, J Zhao, ... Nature cancer 2 (12), 1372-1386, 2021 | 60 | 2021 |
| The efficacy of DNA mismatch repair enzyme immunohistochemistry as a screening test for hypermutated gliomas M McCord, A Steffens, R Javier, KL Kam, K McCortney, C Horbinski Acta neuropathologica communications 8, 1-8, 2020 | 45 | 2020 |
| Monocyte chemotactic protein-1–interleukin-6–osteopontin pathway of intra-aneurysmal tissue healing K Hosaka, K Rojas, HZ Fazal, MB Schneider, J Shores, V Federico, ... Stroke 48 (4), 1052-1060, 2017 | 40 | 2017 |
| Whole Genome Sequencing of Newly Established Pancreatic Cancer Lines Identifies Novel Somatic Mutation (c.2587G>A) in Axon Guidance Receptor Plexin A1 … R Sorber, Y Teper, A Abisoye-Ogunniyan, JJ Waterfall, S Davis, JK Killian, ... PLoS One 11 (3), e0149833, 2016 | 28 | 2016 |
| Neuropathology of anti-amyloid-β immunotherapy: a case report RJ Castellani, ED Shanes, M McCord, NJ Reish, ME Flanagan, ... Journal of Alzheimer's Disease 93 (2), 803-813, 2023 | 22 | 2023 |
| Validation of whole genome methylation profiling classifier for central nervous system tumors L Santana-Santos, KL Kam, D Dittmann, S De Vito, M McCord, P Jamshidi, ... The Journal of Molecular Diagnostics 24 (8), 924-934, 2022 | 13 | 2022 |
| High-grade glioma with pleomorphic and pseudopapillary features (HPAP): a proposed type of circumscribed glioma in adults harboring frequent TP53 mutations … D Pratt, Z Abdullaev, A Papanicolau-Sengos, C Ketchum, ... Acta neuropathologica 143 (3), 403-414, 2022 | 13 | 2022 |
| Adenosine A2A receptor activation enhances blood–tumor barrier permeability in a rodent glioma model A Vézina, M Manglani, DA Morris, B Foster, M McCord, H Song, M Zhang, ... Molecular Cancer Research 19 (12), 2081-2095, 2021 | 13 | 2021 |
| Delirium associated with memantine use in a patient with vascular dementia D Witter, M McCord, U Suryadevara Journal of Clinical Psychopharmacology 35 (6), 736-738, 2015 | 11 | 2015 |
| Modeling therapy-driven evolution of glioblastoma with patient-derived xenografts M McCord, E Bartom, K Burdett, A Baran, FD Eckerdt, IV Balyasnikova, ... Cancers 14 (22), 5494, 2022 | 10 | 2022 |
| Do tumor and ventricular volume predict the need for postresection shunting in colloid cyst patients? KJ Weaver, M McCord, D Neal, F Bova, D Rajon, A Quinones-Hinojosa, ... Journal of neurosurgery 125 (3), 585-590, 2016 | 7 | 2016 |
| Operative and Mid‐Term Outcomes of Thoracic Aortic Operation in Octogenarians and Beyond A Karimi, MR McCord, TM Beaver, TD Martin, PJ Hess, AW Beck, ... Journal of Cardiac Surgery 31 (5), 334-340, 2016 | 7 | 2016 |
| Disappearance of MMR-deficient subclones after controlled IL-12 and PD-1 inhibition in a glioma patient M McCord, RV Lukas, C Amidei, N Demars, A Gelb, J Buck, S Sachdev, ... Neuro-Oncology Advances 3 (1), vdab045, 2021 | 6 | 2021 |
| Spinocerebellar ataxia type 3: a case report and literature review MR McCord, EH Bigio, KL Kam, V Fischer, F Obeidin, CL White, DJ Brat, ... Journal of Neuropathology & Experimental Neurology 79 (6), 641-646, 2020 | 6 | 2020 |
| Targeting WNT signaling for multifaceted glioblastoma therapy. Front Cell Neurosci 11: 318 M McCord, YS Mukouyama, MR Gilbert, S Jackson | 6 | 2017 |
| ERK1/2 phosphorylation predicts survival in recurrent glioblastoma following intracerebral and adjuvant PD-1/CTLA-4 immunotherapy: A REMARK-guided analysis VA Arrieta, J Duerinck, KB Burdett, KJ Habashy, W Geens, A Gould, ... Clinical Cancer Research 30 (2), 379-388, 2024 | 4 | 2024 |
| Variant allelic frequency of driver mutations predicts success of genomic DNA methylation classification in central nervous system tumors P Jamshidi, M McCord, K Galbraith, L Santana-Santos, LJ Jennings, ... Acta neuropathologica 145 (3), 365-367, 2023 | 4 | 2023 |
Craig HorbinskiNorthwestern University在 northwestern.edu 的电子邮件经过验证
